FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118484025> ?p ?o ?g. }

• W3118484025 endingPage "140" @default.
• W3118484025 startingPage "128" @default.
• W3118484025 abstract "Diabetic nephropathy (DN) is a common complication of diabetes. Yishen capsule, composed of Chinese herbs, improves the clinical outcome in DN patients. However, its therapeutic potential and underlying mechanisms require further elucidation. Hence, our study aimed to investigate the underlying mechanisms and therapeutic potential of Yishen capsule in DN. Streptozotocin-induced DN rats were treated with Yishen capsules (1.25 g/kg/day) for 8 weeks. Then, blood glucose and urine protein levels were measured. Hematoxylin and eosin staining and western blot assays were used to examine the histologic changes and gene expression, respectively, in kidney samples. Mouse podocytes were treated with rat serum containing Yishen capsule and transmission electron microscopy was used to examine autophagosome formation. Cell counting kit-8 assay was performed to examine cell proliferation. Western blot and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analyses were conducted to detect changes in gene expression. The localization of SIRT1 was examined in the podocytes using immunocytofluorescence assay. We found that Yishen capsule relieved pathological changes, decreased urine protein, increased SIRT1, LC3-II, and Beclin-1 expression, and reduced acetylated NF-κB p65 expression in vivo. In addition, rat serum containing Yishen capsule showed improved podocyte proliferation, promoted the mRNA and protein levels of LC3-II and Beclin-1, and induced nuclear translocation of SIRT1. Furthermore, it increased SIRT1 expression and decreased mRNA level of NF-κB in the serum. SIRT1 inhibitor increased the mRNA level of NF-κB. Our data suggests that Yishen capsule improves DN by promoting podocyte autophagy via the SIRT1/NF-κB pathway." @default.
• W3118484025 created "2021-01-18" @default.
• W3118484025 creator A5004097301 @default.
• W3118484025 creator A5007691211 @default.
• W3118484025 creator A5008307849 @default.
• W3118484025 creator A5031793941 @default.
• W3118484025 creator A5034485071 @default.
• W3118484025 creator A5041181413 @default.
• W3118484025 creator A5050380450 @default.
• W3118484025 creator A5060636882 @default.
• W3118484025 creator A5063089557 @default.
• W3118484025 creator A5063923009 @default.
• W3118484025 creator A5074479505 @default.
• W3118484025 creator A5079142623 @default.
• W3118484025 creator A5086013260 @default.
• W3118484025 date "2021-01-01" @default.
• W3118484025 modified "2023-09-30" @default.
• W3118484025 title "Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy" @default.
• W3118484025 cites W1123707573 @default.
• W3118484025 cites W133756765 @default.
• W3118484025 cites W1964438031 @default.
• W3118484025 cites W1972556189 @default.
• W3118484025 cites W1980377950 @default.
• W3118484025 cites W2029220328 @default.
• W3118484025 cites W2035019335 @default.
• W3118484025 cites W2045373134 @default.
• W3118484025 cites W2054951699 @default.
• W3118484025 cites W2065195323 @default.
• W3118484025 cites W2065240058 @default.
• W3118484025 cites W2085812232 @default.
• W3118484025 cites W2088381487 @default.
• W3118484025 cites W2106561187 @default.
• W3118484025 cites W2215856261 @default.
• W3118484025 cites W2278547338 @default.
• W3118484025 cites W2291105686 @default.
• W3118484025 cites W2337879247 @default.
• W3118484025 cites W2518283902 @default.
• W3118484025 cites W2550324269 @default.
• W3118484025 cites W2569274667 @default.
• W3118484025 cites W2604961095 @default.
• W3118484025 cites W2624312794 @default.
• W3118484025 cites W2738800376 @default.
• W3118484025 cites W2788823940 @default.
• W3118484025 cites W2854408917 @default.
• W3118484025 cites W2987498568 @default.
• W3118484025 cites W2990151396 @default.
• W3118484025 doi "https://doi.org/10.1080/0886022x.2020.1869043" @default.
• W3118484025 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7808384" @default.
• W3118484025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33427556" @default.
• W3118484025 hasPublicationYear "2021" @default.
• W3118484025 type Work @default.
• W3118484025 sameAs 3118484025 @default.
• W3118484025 citedByCount "15" @default.
• W3118484025 countsByYear W31184840252021 @default.
• W3118484025 countsByYear W31184840252022 @default.
• W3118484025 countsByYear W31184840252023 @default.
• W3118484025 crossrefType "journal-article" @default.
• W3118484025 hasAuthorship W3118484025A5004097301 @default.
• W3118484025 hasAuthorship W3118484025A5007691211 @default.
• W3118484025 hasAuthorship W3118484025A5008307849 @default.
• W3118484025 hasAuthorship W3118484025A5031793941 @default.
• W3118484025 hasAuthorship W3118484025A5034485071 @default.
• W3118484025 hasAuthorship W3118484025A5041181413 @default.
• W3118484025 hasAuthorship W3118484025A5050380450 @default.
• W3118484025 hasAuthorship W3118484025A5060636882 @default.
• W3118484025 hasAuthorship W3118484025A5063089557 @default.
• W3118484025 hasAuthorship W3118484025A5063923009 @default.
• W3118484025 hasAuthorship W3118484025A5074479505 @default.
• W3118484025 hasAuthorship W3118484025A5079142623 @default.
• W3118484025 hasAuthorship W3118484025A5086013260 @default.
• W3118484025 hasBestOaLocation W31184840251 @default.
• W3118484025 hasConcept C104317684 @default.
• W3118484025 hasConcept C105580179 @default.
• W3118484025 hasConcept C126322002 @default.
• W3118484025 hasConcept C127561419 @default.
• W3118484025 hasConcept C134018914 @default.
• W3118484025 hasConcept C153911025 @default.
• W3118484025 hasConcept C190283241 @default.
• W3118484025 hasConcept C203522944 @default.
• W3118484025 hasConcept C2776415932 @default.
• W3118484025 hasConcept C2777146197 @default.
• W3118484025 hasConcept C2779280383 @default.
• W3118484025 hasConcept C2779561371 @default.
• W3118484025 hasConcept C2779922275 @default.
• W3118484025 hasConcept C2780091579 @default.
• W3118484025 hasConcept C4692481 @default.
• W3118484025 hasConcept C55493867 @default.
• W3118484025 hasConcept C555293320 @default.
• W3118484025 hasConcept C71924100 @default.
• W3118484025 hasConcept C86803240 @default.
• W3118484025 hasConceptScore W3118484025C104317684 @default.
• W3118484025 hasConceptScore W3118484025C105580179 @default.
• W3118484025 hasConceptScore W3118484025C126322002 @default.
• W3118484025 hasConceptScore W3118484025C127561419 @default.
• W3118484025 hasConceptScore W3118484025C134018914 @default.
• W3118484025 hasConceptScore W3118484025C153911025 @default.
• W3118484025 hasConceptScore W3118484025C190283241 @default.
• W3118484025 hasConceptScore W3118484025C203522944 @default.

• next